Protalix
1 known investors
Protalix BioTherapeutics develops and markets enzyme replacement therapies for rare diseases, having brought two such therapies to market. It operates in the biopharmaceutical industry focused on rare-disease treatments.
Investors · 1
In the news
Frequently asked questions
- What does Protalix do?
- Protalix BioTherapeutics develops and markets enzyme replacement therapies for rare diseases, having brought two such therapies to market. It operates in the biopharmaceutical industry focused on rare-disease treatments.
- Who are Protalix's investors?
- Protalix's investors include Pontifax Venture Capital.